FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043011018> ?p ?o ?g. }

• W3043011018 endingPage "153099" @default.
• W3043011018 startingPage "153099" @default.
• W3043011018 abstract "Researchers have discovered a large number of DNA methylation patterns in human cancer. These cancer-specific methylation patterns can provide information for the diagnosis, treatment, and prognosis of cancer. Methylation studies can find new biomarkers based on epigenetic analysis and apply these biomarkers to clinical oncology. Many studies on the association between RAASF1A methylation status and susceptibility to hepatitis B virus (HBV)/hepatitis C virus (HCV)-induced hepatocellular carcinoma (HCC) have reached controversial conclusions. Hence, the current review comprehensively assessed the correlation between Ras association domain family 1A (RASSF1A) methylation and the risk of the HCV/HBV-induced HCC. The appropriated publications were extracted in EMBASE, PubMed, Web of Science, Cochrane Library, and China National Knowledge Infrastructure databases using STATA 5.0 software. The odds ratios (ORs) with 95 % confidence interval (95 % CI) of RASSF1A methylation were computed. A total of 1015 HBV/HCV-related HCC samples, 124 non-HBV/HCV-related HCC (NBNC-HCC) samples, and 1225 nontumorous controls were extracted and examined in this research. The frequency of the methylated RASSF1A in the HBV/HCV-related tumor cases displayed a significantly increased OR compared with the overall nontumor samples (OR = 19.372, 95 % CI = 11.060–33.931, P = 0.000). The frequency of the methylated RASSF1A in HBV/HCV-related neoplasm cases displayed a significantly increased OR compared with the non-HBV/HCV-related neoplasm (NBNC-neoplasm) samples (OR = 2.150, 95 % CI = 1.398–3.308, P = 0.000). Compared with normal, chronic hepatitis B or C, cirrhosis, and paracancerous samples, the pooled OR of the RASSF1A promoter methylation in the HBV/HCV-induced HCC samples was 62.785(95 % CI = 35.224–111.909), 25.07 (95 % CI = 13.85–45.36), 6.89 (95 % CI = 3.33–14.264) and 9.02 (95 % CI = 0.91–89.80), respectively. The rate of RASSF1A hypermethylation was robustly correlated with tumor size and vascular invasion, and the pooled OR was 0.346 (95 % CI = 0.210 – 0.569) and 0.081 (95 % CI = 0.022 – 0.303), respectively. Results showed robust associations between RASSF1A gene methylation in promoter region and enhanced HBV/HCV-related HCC susceptibility, thereby revealing that RASSF1A methylation status may serve as an important indicator for HCC oncogenesis." @default.
• W3043011018 created "2020-07-23" @default.
• W3043011018 creator A5000150232 @default.
• W3043011018 creator A5018105912 @default.
• W3043011018 creator A5045558700 @default.
• W3043011018 creator A5069791825 @default.
• W3043011018 creator A5073216396 @default.
• W3043011018 creator A5073800642 @default.
• W3043011018 creator A5086861827 @default.
• W3043011018 date "2020-10-01" @default.
• W3043011018 modified "2023-10-01" @default.
• W3043011018 title "Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis" @default.
• W3043011018 cites W1690185597 @default.
• W3043011018 cites W1908943485 @default.
• W3043011018 cites W1963822977 @default.
• W3043011018 cites W1969810200 @default.
• W3043011018 cites W1982154889 @default.
• W3043011018 cites W1986838855 @default.
• W3043011018 cites W2000940387 @default.
• W3043011018 cites W2003825154 @default.
• W3043011018 cites W2005655114 @default.
• W3043011018 cites W2010338398 @default.
• W3043011018 cites W2041657966 @default.
• W3043011018 cites W2042644795 @default.
• W3043011018 cites W2046100841 @default.
• W3043011018 cites W2046980861 @default.
• W3043011018 cites W2050182207 @default.
• W3043011018 cites W2053741567 @default.
• W3043011018 cites W2087642115 @default.
• W3043011018 cites W2088286295 @default.
• W3043011018 cites W2088985926 @default.
• W3043011018 cites W2089863413 @default.
• W3043011018 cites W2115556288 @default.
• W3043011018 cites W2117847319 @default.
• W3043011018 cites W2121227735 @default.
• W3043011018 cites W2143929604 @default.
• W3043011018 cites W2775769278 @default.
• W3043011018 cites W2911903456 @default.
• W3043011018 cites W4211105405 @default.
• W3043011018 doi "https://doi.org/10.1016/j.prp.2020.153099" @default.
• W3043011018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32853942" @default.
• W3043011018 hasPublicationYear "2020" @default.
• W3043011018 type Work @default.
• W3043011018 sameAs 3043011018 @default.
• W3043011018 citedByCount "7" @default.
• W3043011018 countsByYear W30430110182020 @default.
• W3043011018 countsByYear W30430110182021 @default.
• W3043011018 countsByYear W30430110182022 @default.
• W3043011018 crossrefType "journal-article" @default.
• W3043011018 hasAuthorship W3043011018A5000150232 @default.
• W3043011018 hasAuthorship W3043011018A5018105912 @default.
• W3043011018 hasAuthorship W3043011018A5045558700 @default.
• W3043011018 hasAuthorship W3043011018A5069791825 @default.
• W3043011018 hasAuthorship W3043011018A5073216396 @default.
• W3043011018 hasAuthorship W3043011018A5073800642 @default.
• W3043011018 hasAuthorship W3043011018A5086861827 @default.
• W3043011018 hasBestOaLocation W30430110181 @default.
• W3043011018 hasConcept C104317684 @default.
• W3043011018 hasConcept C121608353 @default.
• W3043011018 hasConcept C126322002 @default.
• W3043011018 hasConcept C143998085 @default.
• W3043011018 hasConcept C150194340 @default.
• W3043011018 hasConcept C156957248 @default.
• W3043011018 hasConcept C190727270 @default.
• W3043011018 hasConcept C203014093 @default.
• W3043011018 hasConcept C2522874641 @default.
• W3043011018 hasConcept C2776231280 @default.
• W3043011018 hasConcept C2776408679 @default.
• W3043011018 hasConcept C2776455275 @default.
• W3043011018 hasConcept C2776478404 @default.
• W3043011018 hasConcept C2777214474 @default.
• W3043011018 hasConcept C2777382497 @default.
• W3043011018 hasConcept C2778019345 @default.
• W3043011018 hasConcept C2780593183 @default.
• W3043011018 hasConcept C33288867 @default.
• W3043011018 hasConcept C44249647 @default.
• W3043011018 hasConcept C54355233 @default.
• W3043011018 hasConcept C71924100 @default.
• W3043011018 hasConcept C86803240 @default.
• W3043011018 hasConcept C90924648 @default.
• W3043011018 hasConcept C95190672 @default.
• W3043011018 hasConceptScore W3043011018C104317684 @default.
• W3043011018 hasConceptScore W3043011018C121608353 @default.
• W3043011018 hasConceptScore W3043011018C126322002 @default.
• W3043011018 hasConceptScore W3043011018C143998085 @default.
• W3043011018 hasConceptScore W3043011018C150194340 @default.
• W3043011018 hasConceptScore W3043011018C156957248 @default.
• W3043011018 hasConceptScore W3043011018C190727270 @default.
• W3043011018 hasConceptScore W3043011018C203014093 @default.
• W3043011018 hasConceptScore W3043011018C2522874641 @default.
• W3043011018 hasConceptScore W3043011018C2776231280 @default.
• W3043011018 hasConceptScore W3043011018C2776408679 @default.
• W3043011018 hasConceptScore W3043011018C2776455275 @default.
• W3043011018 hasConceptScore W3043011018C2776478404 @default.
• W3043011018 hasConceptScore W3043011018C2777214474 @default.
• W3043011018 hasConceptScore W3043011018C2777382497 @default.
• W3043011018 hasConceptScore W3043011018C2778019345 @default.
• W3043011018 hasConceptScore W3043011018C2780593183 @default.

• next